Metabolism of dexamethasone in the human kidney: Nicotinamide adenine dinucleotide-dependent 11 beta-reduction

被引:33
作者
Diederich, S
Hanke, B
Oelkers, W
Bahr, V
机构
关键词
D O I
10.1210/jc.82.5.1598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, two distinct isoenzymes of 11 beta-hydroxysteroid-dehydrogenase (11 beta-HSD) have been cloned and characterized in several species: The isoenzyme 11 beta-HSD-I is widely distributed, bidirectional, prefers NADP(H) and has a low substrate affinity. The isoenzyme 11 beta-HSD-II seems to exclusively oxidize physiological glucocorticoids, uses NAD as cosubstrate, has high substrate affinity, and is only found in mineralocorticoid target tissues and the placenta. Synthetic steroids fluorinated in position 9, however, sue rapidly reduced by human kidney cortex slices. We attempted to find out which isoenzyme is responsible for this unexpected reductase activity. We studied the 11 beta-HSD activity towards cortisol (F)/cortisone (E) and dexamethasone (D)/11-dehydro-dexamethasone (DH-D) in microsomes prepared from human kidney cortex. For the reaction E to F (not for DH-D to D!), glucose-g-phosphate and glucose-6-phosphate-dehydrogenase had to be added as a NADH/NADPH-regenerating system. Oxidation off to E:NAD was the exclusively used cosubstrate; the affinity [Michael's constant (K-m) for F = 25.5 nmol/L and the maximum velocity (V-max = 22.9 nmol/mg/min) were high. Reduction of E to F:Without the NADH/NADPH-regenerating system, this reaction was very slow. With this system, the K-m value for E was in the nanomolar range (80.6 nmol/L) and the V-max value was very low (0.88 nmol/mg/min). The reaction was clearly NADH-preferring. For the steroid pair F/E, the quotient V-max(oxidation)/V-max(reduction) (=26) demonstrates an equilibrium far on the 11-keto side. Oxidation of D to DH-D: With NAD as the only used cosubstrate, the kinetic analysis is compatible with the existence of two different NAD-dependent isoenzymes: K-m for D = 327 nmol/L, V-max = 53.5 nmol/mg/min and K-m For D = 81.2 nmol/L; V-max = 20.4 nmol/mg/min. Reduction of DH-D to D: The maximum velocity was higher than that of all other reactions tested: V-max = 226.0 nmol/mg/min, The reaction was exclusively NADH-dependent; the K-m value for]DH-D was 68.4 nmol/L. Far D/DH-D, the ratio V-max(oxidation)/V-max(reduction) was 0.24, demonstrating a shift to reductase activity with the reaction equilibrium far on the Il-hydroxy side. The reaction F to E was inhibited by E, DH-D, and D in a concentration-dependent manner, In conclusion the cosubstrate dependence, the K-m value of the oxidation off and the product inhibition are in good correspondence with data for the cloned human 11 beta-HSD-II. The NADH-dependent 11 beta-reduction of E and especially of DH-D are inconsistent with the dogma of an unidirectional 11 beta-HSD-II, The preference of D for the reductase reaction in human kidney slices is probably caused by the fluor atom in position 9, is catalyzed by 11 beta-HSD-II, and leads to an activation of II-DH-D to D in the human kidney.
引用
收藏
页码:1598 / 1602
页数:5
相关论文
共 25 条
[1]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[2]   CLONING AND TISSUE DISTRIBUTION OF THE HUMAN 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2 ENZYME [J].
ALBISTON, AL ;
OBEYESEKERE, VR ;
SMITH, RE ;
KROZOWSKI, ZS .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 105 (02) :R11-R17
[3]   CLONING OF HUMAN MINERALOCORTICOID RECEPTOR COMPLEMENTARY-DNA - STRUCTURAL AND FUNCTIONAL KINSHIP WITH THE GLUCOCORTICOID RECEPTOR [J].
ARRIZA, JL ;
WEINBERGER, C ;
CERELLI, G ;
GLASER, TM ;
HANDELIN, BL ;
HOUSMAN, DE ;
EVANS, RM .
SCIENCE, 1987, 237 (4812) :268-275
[4]   COMPARISON OF 7 METHODS FOR FITTING MICHAELIS-MENTEN EQUATION [J].
ATKINS, GL ;
NIMMO, IA .
BIOCHEMICAL JOURNAL, 1975, 149 (03) :775-777
[5]   RADIORECEPTOR ASSAY FOR EVALUATION OF PLASMA GLUCOCORTICOID ACTIVITY OF NATURAL AND SYNTHETIC STEROIDS IN MAN [J].
BALLARD, PL ;
CARTER, JP ;
GRAHAM, BS ;
BAXTER, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 41 (02) :290-304
[6]   Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2 [J].
Brown, RW ;
Chapman, KE ;
Kotelevtsev, Y ;
Yau, JLW ;
Lindsay, RS ;
Brett, L ;
Leckie, C ;
Murad, P ;
Lyons, V ;
Mullins, JJ ;
Edwards, CRW ;
Seckl, JR .
BIOCHEMICAL JOURNAL, 1996, 313 :1007-1017
[7]  
BUSH IE, 1962, PHARMACOL REV, V14, P317
[8]   METABOLISM OF 11-OXYGENATED STEROIDS .3. SOME 1-DEHYDRO + 9ALPHA-FLUORO STEROIDS [J].
BUSH, IE ;
MAHESH, VB .
BIOCHEMICAL JOURNAL, 1964, 93 (02) :236-&
[9]   METABOLISM OF 11-OXYGENATED STEROIDS - METABOLISM IN VITRO BY PREPARATIONS OF LIVER [J].
BUSH, IE ;
HUNTER, SA ;
MEIGS, RA .
BIOCHEMICAL JOURNAL, 1968, 107 (02) :239-&
[10]   Human kidney 11 beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? [J].
Diederich, S ;
Quinkler, M ;
Miller, K ;
Heilmann, P ;
Schoneshofer, M ;
Oelkers, W .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (03) :301-307